Filter Results:
(792)
Show Results For
- All HBS Web
(1,551)
- People (1)
- News (333)
- Research (792)
- Multimedia (8)
- Faculty Publications (573)
Show Results For
- All HBS Web
(1,551)
- People (1)
- News (333)
- Research (792)
- Multimedia (8)
- Faculty Publications (573)
Sort by
- December 2021
- Case
Grace Capital
By: Sara Fleiss, Robin Greenwood, Eren Kuzucu and Denise Han
In March 2020, the global pandemic was delivering a dose of volatility to the U.S. economy. Catherine Faddis, the CIO of Grace Capital, a Boston-based long-only equity manager, analyzed movements in her portfolio while eyeing previously shelved opportunities to invest... View Details
Keywords: Preferred Stock; COVID-19 Pandemic; Economy; Health Pandemics; Volatility; Entrepreneurship; Finance; Investment; Strategy; Decision Making; Investment Portfolio; Financial Services Industry; United States
Fleiss, Sara, Robin Greenwood, Eren Kuzucu, and Denise Han. "Grace Capital." Harvard Business School Case 222-052, December 2021.
- July 2021 (Revised July 2022)
- Case
Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care
By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab
Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’... View Details
Keywords: Health Care and Treatment; Outcome or Result; Cost Management; Activity Based Costing and Management; Mobile and Wireless Technology; Health Testing and Trials; Surveys; Health Industry; Boston
Kaplan, Robert S., Navraj S. Nagra, and Syed S. Shehab. "Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care." Harvard Business School Case 122-010, July 2021. (Revised July 2022.)
- August 2022 (Revised August 2023)
- Case
NOW PT (A): Should We Invest?
By: George A Riedel, Amy Klopfenstein and Mel Martin
In fall 2021, a team of students from the HBS Impact Investing Fund considered Neurologic Optimal Wellness Physical Therapy (NOW PT) for a potential investment. Dr. Banks, the founder of NOW PT, drove to visit patients. She sought an investment from the fund to open a... View Details
Keywords: Entrepreneurship; Social Entrepreneurship; Finance; Investment; Health; Health Care and Treatment; Medical Specialties; Buildings and Facilities; Health Industry; Health Industry; North and Central America; United States; Massachusetts
Riedel, George A., Amy Klopfenstein, and Mel Martin. "NOW PT (A): Should We Invest?" Harvard Business School Case 323-009, August 2022. (Revised August 2023.)
- February 2010
- Teaching Note
Koo Foundation Sun Yat-Sen Cancer Center: Breast Cancer Care in Taiwan (TN)
By: Michael E. Porter and Jennifer F Baron
Teaching Note for [710425]. View Details
- September 2022
- Article
Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities
By: Leemore Dafny, Christopher Ody and Teresa Rokos
The federal Anti-Kickback Statute prohibits biopharmaceutical manufacturers from directly covering Medicare enrollees’ out-of-pocket spending for the drugs they manufacture, but manufacturers may donate to independent patient assistance charities and earmark donations... View Details
Keywords: Cost Sharing; Prescription Drugs; Drug Spending; Medicare; Dual Eligibility; Cost; Health Care and Treatment; Philanthropy and Charitable Giving; Pharmaceutical Industry
Dafny, Leemore, Christopher Ody, and Teresa Rokos. "Giving a Buck or Making a Buck? Donations by Pharmaceutical Manufacturers to Independent Patient Assistance Charities." Health Affairs 41, no. 9 (September 2022).
- 08 Sep 2015
- First Look
September 8, 2015
that exists at the top of organizational hierarchies. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=49601 forthcoming Management Science Financing Risk and Innovation By: Nanda, Ramana, and Matthew Rhodes-Kropf... View Details
Keywords: Carmen Nobel
- October 2005 (Revised September 2006)
- Case
DentalCorp
By: Richard G. Hamermesh and Ricardo Reisen de Pinho
DentalCorp is the fifth largest provider of dental insurance in Brazil and has tripled its sales in the past two years. Whether to expand to Chile or to continue expansion in Brazil is the major strategic choice facing the company at the end of 2004. View Details
Keywords: International Finance; Expansion; Entrepreneurship; Health Care and Treatment; Global Strategy; Health Industry; Health Industry; Brazil; Chile
Hamermesh, Richard G., and Ricardo Reisen de Pinho. "DentalCorp." Harvard Business School Case 806-023, October 2005. (Revised September 2006.)
- September–October 2020
- Article
The Past, Present, and (Near) Future of Gene Therapy and Gene Editing
By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details
Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change
Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).
- February 2006 (Revised February 2009)
- Case
AIDS in Brazil
By: Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details
Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)
- March 2011
- Teaching Note
PrimedicProviding Primary Care in Mexico (TN)
Teaching Note for 811040. View Details
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
require a shift in the traditional philanthropy mindset, Hamermesh says, from funding the construction of a new cancer pavilion to financing the development of specific therapies for cancer subtypes—a less visible, but potentially more... View Details
- 29 May 2020
- Op-Ed
How Leaders Are Fighting Food Insecurity on Three Continents
according to the Nwunelis. Sahel Capital Agribusiness Managers, where Mezuo Nwuneli is the managing partner, provides capital and technical assistance to food and agriculture-focused small- to medium-sized enterprises (SMEs) through the Fund for Agricultural View Details
- June 2011
- Article
Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial
By: Leslie K. John, George Loewenstein, Andrea Troxel, Laurie Norton, Jennifer Fassbender and Kevin Volpp
John, Leslie K., George Loewenstein, Andrea Troxel, Laurie Norton, Jennifer Fassbender, and Kevin Volpp. "Financial Incentives for Extended Weight Loss: A Randomized, Controlled Trial." Journal of General Internal Medicine 26, no. 6 (June 2011): 621–626.
- 30 Apr 2001
- What Do You Think?
Dot.Com Shakeout: Chess or Roulette?
was that of T. N. Rao: "There is an immense business opportunity now for all the investing companies to pick up some very good dot.coms that have very sound business models. It is just that the principles of assessing the health of... View Details
Keywords: by James Heskett
- April 1, 2024
- Other Article
Paying For AI In Healthcare: Setting The Right Precedent Amidst Growing Use
By: Mitchell Tang, Kaylee Wilson and Ateev Mehrotra
Tang, Mitchell, Kaylee Wilson, and Ateev Mehrotra. "Paying For AI In Healthcare: Setting The Right Precedent Amidst Growing Use." Health Affairs Forefront (April 1, 2024).
- January 2011 (Revised January 2012)
- Supplement
The Case of the Unidentified Healthcare Companies2010 (CW)
By: Richard M.J. Bohmer, Ethan S Bernstein, Margarita Krivitski and Srinidhi Reddy
This case presents financial statements and selected rations for 14 unidentified healthcare organizations and asks that each set of financial information be matched with one of the following healthcare companies: a biotechnology firm, a community nursing company, a... View Details
- 04 Apr 2017
- First Look
First Look at New Research, April 4
https://cb.hbsp.harvard.edu/cbmp/product/817081-PDF-ENG Harvard Business School Case 516-051 Unigrains Unigrains is a French agribusiness-focused private equity firm that has provided specialized financing to France's agribusiness sector... View Details
Keywords: Sean Silverthorne
- August 2002 (Revised August 2002)
- Case
Raiser Senior Services--The Stratford (A)
By: H. Kent Bowen and Alison Berkley Wagonfeld
Focuses on modifying operations to increase profitability at an upscale senior care facility in California. Jennifer Raiser, president of Raiser Senior Services, opened the Stratford in 1992 as a high-end, continuing-care retirement community. Ten years later, the... View Details
Keywords: Cost Management; Profit; Saving; Health Care and Treatment; Age; Management Teams; Problems and Challenges; Ethics; Legal Liability; Business Growth and Maturation; Health Industry; Health Industry; California
Bowen, H. Kent, and Alison Berkley Wagonfeld. "Raiser Senior Services--The Stratford (A)." Harvard Business School Case 603-013, August 2002. (Revised August 2002.)
- July 2019
- Article
The Impact of Price Regulation on the Availability of New Drugs in Germany
By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
Stern, Ariel Dora, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari. "The Impact of Price Regulation on the Availability of New Drugs in Germany." Health Affairs 38, no. 7 (July 2019): 1182–1187.
- Article
Unhealthy Consumerism: The Challenge of Trading Off Price and Quality in Healthcare
By: Kate Barasz and Peter A. Ubel
Over the last decade, healthcare in many parts of the world has shifted toward a more patient-centric, consumeristic model, marked by an emphasis on choice and a proliferation of typical consumer-facing information (e.g., price and quality data). However, while the... View Details
Keywords: Medical Decision-making; Choice; Health Care and Treatment; Quality; Price; Consumer Behavior; Decision Making
Barasz, Kate, and Peter A. Ubel. "Unhealthy Consumerism: The Challenge of Trading Off Price and Quality in Healthcare." Behavioural Public Policy 2, no. 1 (May 2018): 41–55.